BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 1597738)

  • 1. Whole-body positron emission tomography: Part I. Methods and performance characteristics.
    Dahlbom M; Hoffman EJ; Hoh CK; Schiepers C; Rosenqvist G; Hawkins RA; Phelps ME
    J Nucl Med; 1992 Jun; 33(6):1191-9. PubMed ID: 1597738
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Attenuation correction in whole-body FDG oncological studies: the role of statistical reconstruction.
    Lonneux M; Borbath I; Bol A; Coppens A; Sibomana M; Bausart R; Defrise M; Pauwels S; Michel C
    Eur J Nucl Med; 1999 Jun; 26(6):591-8. PubMed ID: 10369944
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Whole-body positron emission tomography in clinical oncology: comparison between attenuation-corrected and uncorrected images.
    Bengel FM; Ziegler SI; Avril N; Weber W; Laubenbacher C; Schwaiger M
    Eur J Nucl Med; 1997 Sep; 24(9):1091-8. PubMed ID: 9283100
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Cancer detection with whole-body FDG PET images without attenuation correction].
    Yasuda S; Ide M; Takagi S; Shohtsu A; Mitomi T; Kobayashi S; Suzuki Y
    Kaku Igaku; 1996 Apr; 33(4):367-73. PubMed ID: 8683875
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Value of iterative reconstruction, attenuation correction, and image fusion in the interpretation of FDG PET images with an integrated dual-head coincidence camera and X-ray-based attenuation maps.
    Delbeke D; Martin WH; Patton JA; Sandler MP
    Radiology; 2001 Jan; 218(1):163-71. PubMed ID: 11152796
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Three-dimensional imaging characteristics of the HEAD PENN-PET scanner.
    Karp JS; Freifelder R; Geagan MJ; Muehllehner G; Kinahan PE; Lewitt RM; Shao L
    J Nucl Med; 1997 Apr; 38(4):636-43. PubMed ID: 9098216
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optimal dose of 18F-FDG required for whole-body PET using an LSO PET camera.
    Everaert H; Vanhove C; Lahoutte T; Muylle K; Caveliers V; Bossuyt A; Franken PR
    Eur J Nucl Med Mol Imaging; 2003 Dec; 30(12):1615-9. PubMed ID: 14504831
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of the performance of a whole-body positron imaging system with attenuation correction.
    Ota T; Ito K; Tadokoro M; Kato T; Nishino M; Amano M; Ishigaki T
    Radiat Med; 1995; 13(3):121-8. PubMed ID: 7569003
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of patient weight and emission scan duration on PET/CT image quality and lesion detectability.
    Halpern BS; Dahlbom M; Quon A; Schiepers C; Waldherr C; Silverman DH; Ratib O; Czernin J
    J Nucl Med; 2004 May; 45(5):797-801. PubMed ID: 15136629
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Whole-body PET: physiological and artifactual fluorodeoxyglucose accumulations.
    Engel H; Steinert H; Buck A; Berthold T; Huch Böni RA; von Schulthess GK
    J Nucl Med; 1996 Mar; 37(3):441-6. PubMed ID: 8772641
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhanced FDG-PET tumor imaging with correlation-coefficient filtered influx-constant images.
    Zasadny KR; Wahl RL
    J Nucl Med; 1996 Feb; 37(2):371-4. PubMed ID: 8667078
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Performance characteristics of an eight-ring whole body PET scanner.
    Rota Kops E; Herzog H; Schmid A; Holte S; Feinendegen LE
    J Comput Assist Tomogr; 1990; 14(3):437-45. PubMed ID: 2186064
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Integrated whole-body PET/MR hybrid imaging: clinical experience.
    Quick HH; von Gall C; Zeilinger M; Wiesmüller M; Braun H; Ziegler S; Kuwert T; Uder M; Dörfler A; Kalender WA; Lell M
    Invest Radiol; 2013 May; 48(5):280-9. PubMed ID: 23442775
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Issues in the quantitation of reoriented cardiac PET images.
    Kuhle WG; Porenta G; Huang SC; Phelps ME; Schelbert HR
    J Nucl Med; 1992 Jun; 33(6):1235-42. PubMed ID: 1597745
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Results of a clinical receiver operating characteristic study comparing filtered backprojection and maximum likelihood estimator images in FDG PET studies.
    Llacer J; Veklerov E; Baxter LR; Grafton ST; Griffeth LK; Hawkins RA; Hoh CK; Mazziotta JC; Hoffman EJ; Metz CE
    J Nucl Med; 1993 Jul; 34(7):1198-203. PubMed ID: 8315502
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Easy detection of tumor in oncologic whole-body PET by projection reconstruction images with maximum intensity projection algorithm.
    Fujiwara T; Miyake M; Watanuki S; Mejia MA; Itoh M; Fukuda H
    Ann Nucl Med; 1999 Jun; 13(3):199-203. PubMed ID: 10435383
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improved resolution for PET volume imaging through three-dimensional iterative reconstruction.
    Liow JS; Strother SC; Rehm K; Rottenberg DA
    J Nucl Med; 1997 Oct; 38(10):1623-31. PubMed ID: 9379203
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Whole body skeletal imaging with [18F]fluoride ion and PET.
    Hoh CK; Hawkins RA; Dahlbom M; Glaspy JA; Seeger LL; Choi Y; Schiepers CW; Huang SC; Satyamurthy N; Barrio JR
    J Comput Assist Tomogr; 1993; 17(1):34-41. PubMed ID: 8419436
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Noise reduction in PET attenuation correction by maximum likelihood histogram sharpening of attenuation images.
    Price JC; Bacharach SL; Freedman N; Carson RE
    J Nucl Med; 1996 May; 37(5):786-94. PubMed ID: 8965146
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of positron emission tomography in oncology.
    Glaspy JA; Hawkins R; Hoh CK; Phelps ME
    Oncology (Williston Park); 1993 Jul; 7(7):41-6, 49-50; discussion 50-2, 55. PubMed ID: 8347460
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.